Clinical Trials in Cardiology - O


Maintained by Dr. Olga Shindler. Last update on: February 20, 2001

Alphabetic list:
A / B / C / D / E / F / G / H / I / J / K / L / M /
N / O / P / Q / R / S / T / U / V / W / X / Y / Z /


OARS
Optimal Atherectomy Restenosis Study
J Am Coll Cardiol 1998 Aug;32(2):329-37


OARS (Substudy)
Optimal Atherectomy Restenosis Study
J Am Coll Cardiol 1998 Aug;32(2):329-37


OASIS
Organization to Assess Strategies for Ischemic Syndromes
Circulation 1997; 96:769-777
Circulation 1996; 94(Suppl I):196


OASIS (Warfarin Substudy)
Organization to Assess Strategies for Ischemic Syndromes
Circulation 1998;98:1064-1070


OASIS 2
Organization to Assess Strategies for Ischemic Syndromes
Lancet 1999;353:429-438


OAT
Occluded Artery Trial


OAT
Ochanomizu Aspirin Trials


OAT
Open Artery Trial


OB43
OBjective 43, a later and parallel study to RF2
Panminerva Med 1998 Mar;40(1):55-7
Int J Epidemiol 1992 Oct;21(5):883-92


OCS
Oxford Cholesterol Study


OCSP
Oxfordshire Community Stroke Project


OCTAVE
Omapatrilat Cardiovascular Treatment Assessment Vs. Enalapril


OD1
Organ Disease 1, a multicenter study on coronary atherosclerosis by the Italian CNR


OD2
Organ Disease 2, a multicenter study on cerebrovascular atherosclerosis by the Italian CNR


ODES
Oslo Diet and Exercise Study


OIS
Oslo Ischemia Study


OPALS
Ontario Prehospital Advanced Life Support
JAMA 1999;281:1175-1181


OPCS
Office of Population and Censuses and Surveys


OPERA
Omapatrilat in Persons with Enhanced Risk of Atherosclerotic events


OPTICUS
OPTimization with ICUS to reduce stent restenosis
Am Heart J 1999;137:555-574


OPTIMAAL
OPtimal Trial In Myocardial infarction with the Angiotensin II Antagonist Losartan
Am J Cardiol 1999;83:477-481



Optimal Oral anticoagulant Therapy In patients with Mechanical heart valves
N Engl J Med 1995;333:11-17


OPTIME-CHF
Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure


OPUS
Optimal angioplasty and primary stenting


OPUS-Timi 16
Orbofiban in Patients with Unstable coronary Syndromes
(a) Circulation 2000 Jul 11;102(2):149-56
(b) Clin Cardiol 2000 Nov;23 Suppl 6:VI-14-7


OPUS-TIMI 16
Orbofiban in Patients with Unstable coronary Syndromes, Thrombolysis In Myocardial Infarction 16
Am J Cardiol 2000 Feb 15;85(4):491-3, A10


ORBIT
Oral glycoprotein IIb/IIIa Receptor Blockade to Inhibit Thrombosis
Circulation 1998;98:1268-1278


ORLS
Oxford Record Linkage Study


OSACA
Osaka follow-up Study for ultrasonographic Assessment of Carotid Atherosclerosis


OSCAR
Olive oil Safflower oil Canola oil And Rapeseed oil dietary study


OSDAT
Oslo Study Diet & Antismoking Trial
(A) Am J Med 1986 Feb 14;80(2A):7-11
(B) Prev Med 1985 May;14(3):279-92


OSIRIS
Optimization Study of Infarct Reperfusion Investigated by ST-monitoring


OST
Ottawa Stroke Trials
J Thromb Thrombolysis 1999 Jan;7(1):21-6


OURS
Oxford University Research Study


OURS
Oxygen Utilization Rate Study


OVERTURE
Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events


OXCHECK
OXford and Collaborators HEalth ChecK trial
Health Rep 1994;6(1):160-5


OYS
Oslo Youth Study
(a) Addiction, 90, 561-569
(b) Prevent.Med.1988;17:12-24,
(c) Am J Epidemiol. 1985;122:750-761
(d) Preventive Medicine 1984; 13:256-275

Alphabetic list:
A / B / C / D / E / F / G / H / I / J / K / L / M /
N / O / P / Q / R / S / T / U / V / W / X / Y / Z /


e-mail:shindler@umdnj.edu
Copyright © 1995-2001 Dr. Olga Shindler